internalmdlinx Medical News about metastatic colorectal cancer; cetuximab, capecitabine plus oxaliplatin (XELOX)

Email This Article

Save in My Library

Free Abstract

Borner M et al. - Differences in response rates between the treatment arms indicate that cetuximab may improve outcome with XELOX. The correct place of the cetuximab, oxaliplatin and fluoropyrimidine combinations in first-line treatment of MCC has to be assessed in phase III trials.

--- CLINICAL PHARMACOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Renal Behcet's disease: An update
Seminars in Arthritis and Rheumatism, 08/07/08

Statins and cancer: A systematic review and meta-analysis
European Journal of Cancer, 08/21/08

The efficacy and safety of bucillamine as a second-line DMARD in the treatment of rheumatoid arthritis: A retrospective cohort study
Modern Rheumatology, 08/13/08

...All of Clinical Pharmacology

--- GASTROENTEROLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Infliximab-induced hepatitis: Absence of cross-toxicity with etanercept
Joint, Bone, Spine, 08/19/08

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma
Cancer Chemotherapy and Pharmacology, 08/06/08

Role of Helicobacter pylori Infection in the Treatment and Outcome of Chronic Urticaria
Helicobacter, 08/14/08

...All of Gastroenterology

Sponsor

--- HEMATOLOGY/ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 08/13/08

Quality-of-Life Assessment for Routine Oncology Clinical Practice
The Journal of Supportive Oncology, 06/13/08

Statins and cancer: A systematic review and meta-analysis
European Journal of Cancer, 08/21/08

...All of Hematology/Oncology